EMEA (Europe, Middle East and Africa) Opioid Induced Constipation (OIC) Drugs Market Report 2017

October 2017 | 110 pages | ID: E3E98D740DBEN
QYResearch

Abstracts

In this report, the EMEA Opioid Induced Constipation (OIC) Drugs market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report split EMEA into Europe, the Middle East and Africa, With sales (K Pcs), revenue (Million USD), market share and growth rate of Opioid Induced Constipation (OIC) Drugs for these regions, from 2012 to 2022 (forecast)

• Europe: Germany, France, UK, Russia, Italy and Benelux;
• Middle East: Saudi Arabia, Israel, UAE and Iran;
• Africa: South Africa, Nigeria, Egypt and Algeria.

EMEA Opioid Induced Constipation (OIC) Drugs market competition by top manufacturers/players, with Opioid Induced Constipation (OIC) Drugs sales volume (K Pcs), price (USD/Pcs), revenue (Million USD) and market share for each manufacturer/player; the top players including

• Ironwood Pharmaceuticals Inc
• Daiichi Sankyo Co Ltd
• Pfizer
• Progenics Pharmaceuticals Inc
• Shionogi & Co., Ltd
• Allergan Plc
• Nektar Therapeutics
• Purdue Pharma
• S.L.A. Pharma AG
• Mundipharma International Limited
• Ono Pharmaceutical Co., Ltd
• Takeda Pharmaceutical Company Limited
• Theravance Biopharma Inc
• Valeant Pharmaceuticals International
• Cosmo Pharmaceuticals SA
• Daewoong Pharmaceutical
• C.B. Fleet Company
• Sucampo Pharmaceuticals

On the basis of product, this report displays the sales volume (K Pcs), revenue (Million USD), product price (USD/Pcs), market share and growth rate of each type, primarily split into

• By Drug Type
• Lubiprostone
• Methyl Naltrexone Bromide
• Naldemedine
• Alvimopan
• Other
• By Prescription Type
• Generic and Branded Prescribed Drugs
• Over The Counter Drugs

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume (K Pcs), market share and growth rate of Opioid Induced Constipation (OIC) Drugs for each application, including

• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies

If you have any special requirements, please let us know and we will offer you the report as you want.

Contents

EMEA (Europe, Middle East and Africa) Opioid Induced Constipation (OIC) Drugs Market Report 2017

1 OPIOID INDUCED CONSTIPATION (OIC) DRUGS OVERVIEW

1.1 Product Overview and Scope of Opioid Induced Constipation (OIC) Drugs
1.2 Classification of Opioid Induced Constipation (OIC) Drugs
  1.2.1 EMEA Opioid Induced Constipation (OIC) Drugs Market Size (Sales) Comparison by Type (2012-2022)
  1.2.2 EMEA Opioid Induced Constipation (OIC) Drugs Market Size (Sales) Market Share by Type (Product Category) in 2016
  1.2.3 Lubiprostone
  1.2.4 Methyl Naltrexone Bromide
  1.2.5 Naldemedine
  1.2.6 Alvimopan
  1.2.7 Other
1.3 EMEA Opioid Induced Constipation (OIC) Drugs Market by Application/End Users
  1.3.1 EMEA Opioid Induced Constipation (OIC) Drugs Sales (Volume) and Market Share Comparison by Application (2012-2022
  1.3.2 Hospital Pharmacies
  1.3.3 Retail Pharmacies
  1.3.4 Online Pharmacies
1.4 EMEA Opioid Induced Constipation (OIC) Drugs Market by Region
  1.4.1 EMEA Opioid Induced Constipation (OIC) Drugs Market Size (Value) Comparison by Region (2012-2022)
  1.4.2 Europe Status and Prospect (2012-2022)
  1.4.3 Middle East Status and Prospect (2012-2022)
  1.4.4 Africa Status and Prospect (2012-2022)
1.5 EMEA Market Size (Value and Volume) of Opioid Induced Constipation (OIC) Drugs (2012-2022)
  1.5.1 EMEA Opioid Induced Constipation (OIC) Drugs Sales and Growth Rate (2012-2022)
  1.5.2 EMEA Opioid Induced Constipation (OIC) Drugs Revenue and Growth Rate (2012-2022)

2 EMEA OPIOID INDUCED CONSTIPATION (OIC) DRUGS COMPETITION BY MANUFACTURERS/PLAYERS/SUPPLIERS, REGION, TYPE AND APPLICATION

2.1 EMEA Opioid Induced Constipation (OIC) Drugs Market Competition by Players/Manufacturers
  2.1.1 EMEA Opioid Induced Constipation (OIC) Drugs Sales Volume and Market Share of Major Players (2012-2017)
  2.1.2 EMEA Opioid Induced Constipation (OIC) Drugs Revenue and Share by Players (2012-2017)
  2.1.3 EMEA Opioid Induced Constipation (OIC) Drugs Sale Price by Players (2012-2017)
2.2 EMEA Opioid Induced Constipation (OIC) Drugs (Volume and Value) by Type/Product Category
  2.2.1 EMEA Opioid Induced Constipation (OIC) Drugs Sales and Market Share by Type (2012-2017)
  2.2.2 EMEA Opioid Induced Constipation (OIC) Drugs Revenue and Market Share by Type (2012-2017)
  2.2.3 EMEA Opioid Induced Constipation (OIC) Drugs Sale Price by Type (2012-2017)
2.3 EMEA Opioid Induced Constipation (OIC) Drugs (Volume) by Application
2.4 EMEA Opioid Induced Constipation (OIC) Drugs (Volume and Value) by Region
  2.4.1 EMEA Opioid Induced Constipation (OIC) Drugs Sales and Market Share by Region (2012-2017)
  2.4.2 EMEA Opioid Induced Constipation (OIC) Drugs Revenue and Market Share by Region (2012-2017)
  2.4.3 EMEA Opioid Induced Constipation (OIC) Drugs Sales Price by Region (2012-2017)

3 EUROPE OPIOID INDUCED CONSTIPATION (OIC) DRUGS (VOLUME, VALUE AND SALES PRICE), BY PLAYERS, COUNTRIES, TYPE AND APPLICATION

3.1 Europe Opioid Induced Constipation (OIC) Drugs Sales and Value (2012-2017)
  3.1.1 Europe Opioid Induced Constipation (OIC) Drugs Sales Volume and Growth Rate (2012-2017)
  3.1.2 Europe Opioid Induced Constipation (OIC) Drugs Revenue and Growth Rate (2012-2017)
3.2 Europe Opioid Induced Constipation (OIC) Drugs Sales and Market Share by Type
3.3 Europe Opioid Induced Constipation (OIC) Drugs Sales and Market Share by Application
3.4 Europe Opioid Induced Constipation (OIC) Drugs Sales Volume and Value (Revenue) by Countries
  3.4.1 Europe Opioid Induced Constipation (OIC) Drugs Sales Volume by Countries (2012-2017)
  3.4.2 Europe Opioid Induced Constipation (OIC) Drugs Revenue by Countries (2012-2017)
  3.4.3 Germany Opioid Induced Constipation (OIC) Drugs Sales and Growth Rate (2012-2017)
  3.4.4 France Opioid Induced Constipation (OIC) Drugs Sales and Growth Rate (2012-2017)
  3.4.5 UK Opioid Induced Constipation (OIC) Drugs Sales and Growth Rate (2012-2017)
  3.4.6 Russia Opioid Induced Constipation (OIC) Drugs Sales and Growth Rate (2012-2017)
  3.4.7 Italy Opioid Induced Constipation (OIC) Drugs Sales and Growth Rate (2012-2017)
  3.4.8 Benelux Opioid Induced Constipation (OIC) Drugs Sales and Growth Rate (2012-2017)

4 MIDDLE EAST OPIOID INDUCED CONSTIPATION (OIC) DRUGS (VOLUME, VALUE AND SALES PRICE), BY REGION, TYPE AND APPLICATION

4.1 Middle East Opioid Induced Constipation (OIC) Drugs Sales and Value (2012-2017)
  4.1.1 Middle East Opioid Induced Constipation (OIC) Drugs Sales Volume and Growth Rate (2012-2017)
  4.1.2 Middle East Opioid Induced Constipation (OIC) Drugs Revenue and Growth Rate (2012-2017)
4.2 Middle East Opioid Induced Constipation (OIC) Drugs Sales and Market Share by Type
4.3 Middle East Opioid Induced Constipation (OIC) Drugs Sales and Market Share by Application
4.4 Middle East Opioid Induced Constipation (OIC) Drugs Sales Volume and Value (Revenue) by Countries
  4.4.1 Middle East Opioid Induced Constipation (OIC) Drugs Sales Volume by Countries (2012-2017)
  4.4.2 Middle East Opioid Induced Constipation (OIC) Drugs Revenue by Countries (2012-2017)
  4.4.3 Saudi Arabia Opioid Induced Constipation (OIC) Drugs Sales and Growth Rate (2012-2017)
  4.4.4 Israel Opioid Induced Constipation (OIC) Drugs Sales and Growth Rate (2012-2017)
  4.4.5 UAE Opioid Induced Constipation (OIC) Drugs Sales and Growth Rate (2012-2017)
  4.4.6 Iran Opioid Induced Constipation (OIC) Drugs Sales and Growth Rate (2012-2017)

5 AFRICA OPIOID INDUCED CONSTIPATION (OIC) DRUGS (VOLUME, VALUE AND SALES PRICE) BY PLAYERS, COUNTRIES, TYPE AND APPLICATION

5.1 Africa Opioid Induced Constipation (OIC) Drugs Sales and Value (2012-2017)
  5.1.1 Africa Opioid Induced Constipation (OIC) Drugs Sales Volume and Growth Rate (2012-2017)
  5.1.2 Africa Opioid Induced Constipation (OIC) Drugs Revenue and Growth Rate (2012-2017)
5.2 Africa Opioid Induced Constipation (OIC) Drugs Sales and Market Share by Type
5.3 Africa Opioid Induced Constipation (OIC) Drugs Sales and Market Share by Application
5.4 Africa Opioid Induced Constipation (OIC) Drugs Sales Volume and Value (Revenue) by Countries
  5.4.1 Africa Opioid Induced Constipation (OIC) Drugs Sales Volume by Countries (2012-2017)
  5.4.2 Africa Opioid Induced Constipation (OIC) Drugs Revenue by Countries (2012-2017)
  5.4.3 South Africa Opioid Induced Constipation (OIC) Drugs Sales and Growth Rate (2012-2017)
  5.4.4 Nigeria Opioid Induced Constipation (OIC) Drugs Sales and Growth Rate (2012-2017)
  5.4.5 Egypt Opioid Induced Constipation (OIC) Drugs Sales and Growth Rate (2012-2017)
  5.4.6 Algeria Opioid Induced Constipation (OIC) Drugs Sales and Growth Rate (2012-2017)

6 EMEA OPIOID INDUCED CONSTIPATION (OIC) DRUGS MANUFACTURERS/PLAYERS PROFILES AND SALES DATA

6.1 Ironwood Pharmaceuticals Inc
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Opioid Induced Constipation (OIC) Drugs Product Type, Application and Specification
    6.1.2.1 Product A
    6.1.2.2 Product B
  6.1.3 Ironwood Pharmaceuticals Inc Opioid Induced Constipation (OIC) Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  6.1.4 Main Business/Business Overview
6.2 Daiichi Sankyo Co Ltd
  6.2.1 Company Basic Information, Manufacturing Base and Competitors
  6.2.2 Opioid Induced Constipation (OIC) Drugs Product Type, Application and Specification
    6.2.2.1 Product A
    6.2.2.2 Product B
  6.2.3 Daiichi Sankyo Co Ltd Opioid Induced Constipation (OIC) Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  6.2.4 Main Business/Business Overview
6.3 Pfizer
  6.3.1 Company Basic Information, Manufacturing Base and Competitors
  6.3.2 Opioid Induced Constipation (OIC) Drugs Product Type, Application and Specification
    6.3.2.1 Product A
    6.3.2.2 Product B
  6.3.3 Pfizer Opioid Induced Constipation (OIC) Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  6.3.4 Main Business/Business Overview
6.4 Progenics Pharmaceuticals Inc
  6.4.1 Company Basic Information, Manufacturing Base and Competitors
  6.4.2 Opioid Induced Constipation (OIC) Drugs Product Type, Application and Specification
    6.4.2.1 Product A
    6.4.2.2 Product B
  6.4.3 Progenics Pharmaceuticals Inc Opioid Induced Constipation (OIC) Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  6.4.4 Main Business/Business Overview
6.5 Shionogi & Co., Ltd
  6.5.1 Company Basic Information, Manufacturing Base and Competitors
  6.5.2 Opioid Induced Constipation (OIC) Drugs Product Type, Application and Specification
    6.5.2.1 Product A
    6.5.2.2 Product B
  6.5.3 Shionogi & Co., Ltd Opioid Induced Constipation (OIC) Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  6.5.4 Main Business/Business Overview
6.6 Allergan Plc
  6.6.1 Company Basic Information, Manufacturing Base and Competitors
  6.6.2 Opioid Induced Constipation (OIC) Drugs Product Type, Application and Specification
    6.6.2.1 Product A
    6.6.2.2 Product B
  6.6.3 Allergan Plc Opioid Induced Constipation (OIC) Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  6.6.4 Main Business/Business Overview
6.7 Nektar Therapeutics
  6.7.1 Company Basic Information, Manufacturing Base and Competitors
  6.7.2 Opioid Induced Constipation (OIC) Drugs Product Type, Application and Specification
    6.7.2.1 Product A
    6.7.2.2 Product B
  6.7.3 Nektar Therapeutics Opioid Induced Constipation (OIC) Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  6.7.4 Main Business/Business Overview
6.8 Purdue Pharma
  6.8.1 Company Basic Information, Manufacturing Base and Competitors
  6.8.2 Opioid Induced Constipation (OIC) Drugs Product Type, Application and Specification
    6.8.2.1 Product A
    6.8.2.2 Product B
  6.8.3 Purdue Pharma Opioid Induced Constipation (OIC) Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  6.8.4 Main Business/Business Overview
6.9 S.L.A. Pharma AG
  6.9.1 Company Basic Information, Manufacturing Base and Competitors
  6.9.2 Opioid Induced Constipation (OIC) Drugs Product Type, Application and Specification
    6.9.2.1 Product A
    6.9.2.2 Product B
  6.9.3 S.L.A. Pharma AG Opioid Induced Constipation (OIC) Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  6.9.4 Main Business/Business Overview
6.10 Mundipharma International Limited
  6.10.1 Company Basic Information, Manufacturing Base and Competitors
  6.10.2 Opioid Induced Constipation (OIC) Drugs Product Type, Application and Specification
    6.10.2.1 Product A
    6.10.2.2 Product B
  6.10.3 Mundipharma International Limited Opioid Induced Constipation (OIC) Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  6.10.4 Main Business/Business Overview
6.11 Ono Pharmaceutical Co., Ltd
6.12 Takeda Pharmaceutical Company Limited
6.13 Theravance Biopharma Inc
6.14 Valeant Pharmaceuticals International
6.15 Cosmo Pharmaceuticals SA
6.16 Daewoong Pharmaceutical
6.17 C.B. Fleet Company
6.18 Sucampo Pharmaceuticals

7 OPIOID INDUCED CONSTIPATION (OIC) DRUGS MANUFACTURING COST ANALYSIS

7.1 Opioid Induced Constipation (OIC) Drugs Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Opioid Induced Constipation (OIC) Drugs

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Opioid Induced Constipation (OIC) Drugs Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Opioid Induced Constipation (OIC) Drugs Major Manufacturers in 2016
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 EMEA OPIOID INDUCED CONSTIPATION (OIC) DRUGS MARKET FORECAST (2017-2022)

11.1 EMEA Opioid Induced Constipation (OIC) Drugs Sales, Revenue and Price Forecast (2017-2022)
  11.1.1 EMEA Opioid Induced Constipation (OIC) Drugs Sales and Growth Rate Forecast (2017-2022)
  11.1.2 EMEA Opioid Induced Constipation (OIC) Drugs Revenue and Growth Rate Forecast (2017-2022)
  11.1.3 EMEA Opioid Induced Constipation (OIC) Drugs Price and Trend Forecast (2017-2022)
11.2 EMEA Opioid Induced Constipation (OIC) Drugs Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.3 Europe Opioid Induced Constipation (OIC) Drugs Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.4 Middle Eastt Opioid Induced Constipation (OIC) Drugs Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.5 Africa Opioid Induced Constipation (OIC) Drugs Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.6 EMEA Opioid Induced Constipation (OIC) Drugs Sales Forecast by Type (2017-2022)
11.7 EMEA Opioid Induced Constipation (OIC) Drugs Sales Forecast by Application (2017-2022)

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

13.1 Methodology/Research Approach
  13.1.1 Research Programs/Design
  13.1.2 Market Size Estimation
  13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
  13.2.1 Secondary Sources
  13.2.2 Primary Sources
13.3 Disclaimer


The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Product Picture of Opioid Induced Constipation (OIC) Drugs
Figure EMEA Opioid Induced Constipation (OIC) Drugs Sales Volume (K Pcs) by Type (2012-2022)
Figure EMEA Opioid Induced Constipation (OIC) Drugs Sales Volume Market Share by Type (Product Category) in 2016
Figure Lubiprostone Product Picture
Figure Methyl Naltrexone Bromide Product Picture
Figure Naldemedine Product Picture
Figure Alvimopan Product Picture
Figure Other Product Picture
Figure EMEA Opioid Induced Constipation (OIC) Drugs Sales Volume (K Pcs) by Application (2012-2022)
Figure EMEA Sales Market Share of Opioid Induced Constipation (OIC) Drugs by Application in 2016
Figure Hospital Pharmacies Examples
Table Key Downstream Customer in Hospital Pharmacies
Figure Retail Pharmacies Examples
Table Key Downstream Customer in Retail Pharmacies
Figure Online Pharmacies Examples
Table Key Downstream Customer in Online Pharmacies
Figure EMEA Opioid Induced Constipation (OIC) Drugs Market Size (Million USD) by Region (2012-2022)
Figure Europe Opioid Induced Constipation (OIC) Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure Europe Opioid Induced Constipation (OIC) Drugs Revenue (Million USD) Status and Forecast by Countries
Figure Middle East Opioid Induced Constipation (OIC) Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure Middle East Opioid Induced Constipation (OIC) Drugs Revenue (Million USD) Status and Forecast by Countries
Figure Africa Opioid Induced Constipation (OIC) Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure Africa Opioid Induced Constipation (OIC) Drugs Revenue (Million USD) Status and Forecast by Countries
Figure EMEA Opioid Induced Constipation (OIC) Drugs Sales Volume and Growth Rate (2012-2022)
Figure EMEA Opioid Induced Constipation (OIC) Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure EMEA Opioid Induced Constipation (OIC) Drugs Market Major Players Product Sales Volume (K Pcs) (2012-2017)
Table EMEA Opioid Induced Constipation (OIC) Drugs Sales Volume (K Pcs) of Major Players (2012-2017)
Table EMEA Opioid Induced Constipation (OIC) Drugs Sales Share by Players (2012-2017)
Figure 2016 Opioid Induced Constipation (OIC) Drugs Sales Share by Players
Figure 2017 Opioid Induced Constipation (OIC) Drugs Sales Share by Players
Figure EMEA Opioid Induced Constipation (OIC) Drugs Market Major Players Product Revenue (Million USD) (2012-2017)
Table EMEA Opioid Induced Constipation (OIC) Drugs Revenue (Million USD) by Players (2012-2017)
Table EMEA Opioid Induced Constipation (OIC) Drugs Revenue Share by Players (2012-2017)
Table 2016 EMEA Opioid Induced Constipation (OIC) Drugs Revenue Share by Players
Table 2017 EMEA Opioid Induced Constipation (OIC) Drugs Revenue Share by Players
Table EMEA Opioid Induced Constipation (OIC) Drugs Sale Price (USD/Pcs) by Players (2012-2017)
Table EMEA Opioid Induced Constipation (OIC) Drugs Sales (K Pcs) and Market Share by Type (2012-2017)
Table EMEA Opioid Induced Constipation (OIC) Drugs Sales Share by Type (2012-2017)
Figure Sales Market Share of Opioid Induced Constipation (OIC) Drugs by Type (2012-2017)
Figure EMEA Opioid Induced Constipation (OIC) Drugs Sales Market Share by Type (2012-2017)
Table EMEA Opioid Induced Constipation (OIC) Drugs Revenue (Million USD) and Market Share by Type (2012-2017)
Table EMEA Opioid Induced Constipation (OIC) Drugs Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Opioid Induced Constipation (OIC) Drugs by Type in 2016
Table EMEA Opioid Induced Constipation (OIC) Drugs Sale Price (USD/Pcs) by Type (2012-2017)
Table EMEA Opioid Induced Constipation (OIC) Drugs Sales (K Pcs) and Market Share by Application (2012-2017)
Table EMEA Opioid Induced Constipation (OIC) Drugs Sales Share by Application (2012-2017)
Figure Sales Market Share of Opioid Induced Constipation (OIC) Drugs by Application (2012-2017)
Figure EMEA Opioid Induced Constipation (OIC) Drugs Sales Market Share by Application in 2016
Table EMEA Opioid Induced Constipation (OIC) Drugs Sales (K Pcs) and Market Share by Region (2012-2017)
Table EMEA Opioid Induced Constipation (OIC) Drugs Sales Share by Region (2012-2017)
Figure Sales Market Share of Opioid Induced Constipation (OIC) Drugs by Region (2012-2017)
Figure EMEA Opioid Induced Constipation (OIC) Drugs Sales Market Share in 2016
Table EMEA Opioid Induced Constipation (OIC) Drugs Revenue (Million USD) and Market Share by Region (2012-2017)
Table EMEA Opioid Induced Constipation (OIC) Drugs Revenue Share by Region (2012-2017)
Figure Revenue Market Share of Opioid Induced Constipation (OIC) Drugs by Region (2012-2017)
Figure EMEA Opioid Induced Constipation (OIC) Drugs Revenue Market Share Regions in 2016
Table EMEA Opioid Induced Constipation (OIC) Drugs Sales Price (USD/Pcs) by Region (2012-2017)
Figure Europe Opioid Induced Constipation (OIC) Drugs Sales (K Pcs) and Growth Rate (2012-2017)
Figure Europe Opioid Induced Constipation (OIC) Drugs Revenue and Growth Rate (2012-2017)
Table Europe Opioid Induced Constipation (OIC) Drugs Sales (K Pcs) by Type (2012-2017)
Table Europe Opioid Induced Constipation (OIC) Drugs Market Share by Type (2012-2017)
Figure Europe Opioid Induced Constipation (OIC) Drugs Market Share by Type in 2016
Table Europe Opioid Induced Constipation (OIC) Drugs Sales (K Pcs) by Application (2012-2017)
Table Europe Opioid Induced Constipation (OIC) Drugs Market Share by Application (2012-2017)
Figure Europe Opioid Induced Constipation (OIC) Drugs Market Share by Application in 2016
Table Europe Opioid Induced Constipation (OIC) Drugs Sales (K Pcs) by Countries (2012-2017)
Table Europe Opioid Induced Constipation (OIC) Drugs Sales Market Share by Countries (2012-2017)
Figure Europe Opioid Induced Constipation (OIC) Drugs Sales Market Share by Countries (2012-2017)
Figure Europe Opioid Induced Constipation (OIC) Drugs Sales Market Share by Countries in 2016
Table Europe Opioid Induced Constipation (OIC) Drugs Revenue (Million USD) by Countries (2012-2017)
Table Europe Opioid Induced Constipation (OIC) Drugs Revenue Market Share by Countries (2012-2017)
Figure Europe Opioid Induced Constipation (OIC) Drugs Revenue Market Share by Countries (2012-2017)
Figure Europe Opioid Induced Constipation (OIC) Drugs Revenue Market Share by Countries in 2016
Figure Germany Opioid Induced Constipation (OIC) Drugs Sales (K Pcs) and Growth Rate (2012-2017)
Figure France Opioid Induced Constipation (OIC) Drugs Sales (K Pcs) and Growth Rate (2012-2017)
Figure UK Opioid Induced Constipation (OIC) Drugs Sales (K Pcs) and Growth Rate (2012-2017)
Figure Russia Opioid Induced Constipation (OIC) Drugs Sales (K Pcs) and Growth Rate (2012-2017)
Figure Italy Opioid Induced Constipation (OIC) Drugs Sales (K Pcs) and Growth Rate (2012-2017)
Figure Benelux Opioid Induced Constipation (OIC) Drugs Sales (K Pcs) and Growth Rate (2012-2017)
Figure Middle East Opioid Induced Constipation (OIC) Drugs Sales (K Pcs) and Growth Rate (2012-2017)
Figure Middle East Opioid Induced Constipation (OIC) Drugs Revenue (Million USD) and Growth Rate (2012-2017)
Table Middle East Opioid Induced Constipation (OIC) Drugs Sales (K Pcs) by Type (2012-2017)
Table Middle East Opioid Induced Constipation (OIC) Drugs Market Share by Type (2012-2017)
Figure Middle East Opioid Induced Constipation (OIC) Drugs Market Share by Type (2012-2017)
Table Middle East Opioid Induced Constipation (OIC) Drugs Sales (K Pcs) by Applications (2012-2017)
Table Middle East Opioid Induced Constipation (OIC) Drugs Market Share by Applications (2012-2017)
Figure Middle East Opioid Induced Constipation (OIC) Drugs Sales Market Share by Application in 2016
Table Middle East Opioid Induced Constipation (OIC) Drugs Sales Volume (K Pcs) by Countries (2012-2017)
Table Middle East Opioid Induced Constipation (OIC) Drugs Sales Volume Market Share by Countries (2012-2017)
Figure Middle East Opioid Induced Constipation (OIC) Drugs Sales Volume Market Share by Countries in 2016
Table Middle East Opioid Induced Constipation (OIC) Drugs Revenue (Million USD) by Countries (2012-2017)
Table Middle East Opioid Induced Constipation (OIC) Drugs Revenue Market Share by Countries (2012-2017)
Figure Middle East Opioid Induced Constipation (OIC) Drugs Revenue Market Share by Countries (2012-2017)
Figure Middle East Opioid Induced Constipation (OIC) Drugs Revenue Market Share by Countries in 2016
Figure Saudi Arabia Opioid Induced Constipation (OIC) Drugs Sales (K Pcs) and Growth Rate (2012-2017)
Figure Israel Opioid Induced Constipation (OIC) Drugs Sales (K Pcs) and Growth Rate (2012-2017)
Figure UAE Opioid Induced Constipation (OIC) Drugs Sales (K Pcs) and Growth Rate (2012-2017)
Figure Iran Opioid Induced Constipation (OIC) Drugs Sales (K Pcs) and Growth Rate (2012-2017)
Figure Africa Opioid Induced Constipation (OIC) Drugs Sales (K Pcs) and Growth Rate (2012-2017)
Figure Africa Opioid Induced Constipation (OIC) Drugs Revenue (Million USD) and Growth Rate (2012-2017)
Table Africa Opioid Induced Constipation (OIC) Drugs Sales (K Pcs) by Type (2012-2017)
Table Africa Opioid Induced Constipation (OIC) Drugs Sales Market Share by Type (2012-2017)
Figure Africa Opioid Induced Constipation (OIC) Drugs Sales Market Share by Type (2012-2017)
Figure Africa Opioid Induced Constipation (OIC) Drugs Sales Market Share by Type in 2016
Table Africa Opioid Induced Constipation (OIC) Drugs Sales (K Pcs) by Application (2012-2017)
Table Africa Opioid Induced Constipation (OIC) Drugs Sales Market Share by Application (2012-2017)
Figure Africa Opioid Induced Constipation (OIC) Drugs Sales Market Share by Application (2012-2017)
Table Africa Opioid Induced Constipation (OIC) Drugs Sales Volume (K Pcs) by Countries (2012-2017)
Table Africa Opioid Induced Constipation (OIC) Drugs Sales Market Share by Countries (2012-2017)
Figure Africa Opioid Induced Constipation (OIC) Drugs Sales Market Share by Countries (2012-2017)
Figure Africa Opioid Induced Constipation (OIC) Drugs Sales Market Share by Countries in 2016
Table Africa Opioid Induced Constipation (OIC) Drugs Revenue (Million USD) by Countries (2012-2017)
Table Africa Opioid Induced Constipation (OIC) Drugs Revenue Market Share by Countries (2012-2017)
Figure Africa Opioid Induced Constipation (OIC) Drugs Revenue Market Share by Countries (2012-2017)
Figure Africa Opioid Induced Constipation (OIC) Drugs Revenue Market Share by Countries in 2016
Figure South Africa Opioid Induced Constipation (OIC) Drugs Sales (K Pcs) and Growth Rate (2012-2017)
Figure Nigeria Opioid Induced Constipation (OIC) Drugs Sales (K Pcs) and Growth Rate (2012-2017)
Figure Egypt Opioid Induced Constipation (OIC) Drugs Sales (K Pcs) and Growth Rate (2012-2017)
Figure Algeria Opioid Induced Constipation (OIC) Drugs Sales (K Pcs) and Growth Rate (2012-2017)
Table Ironwood Pharmaceuticals Inc Opioid Induced Constipation (OIC) Drugs Basic Information List
Table Ironwood Pharmaceuticals Inc Opioid Induced Constipation (OIC) Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Ironwood Pharmaceuticals Inc Opioid Induced Constipation (OIC) Drugs Sales (K Pcs) and Growth Rate (2012-2017)
Figure Ironwood Pharmaceuticals Inc Opioid Induced Constipation (OIC) Drugs Sales Market Share in EMEA (2012-2017)
Figure Ironwood Pharmaceuticals Inc Opioid Induced Constipation (OIC) Drugs Revenue Market Share in EMEA (2012-2017)
Table Daiichi Sankyo Co Ltd Opioid Induced Constipation (OIC) Drugs Basic Information List
Table Daiichi Sankyo Co Ltd Opioid Induced Constipation (OIC) Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Daiichi Sankyo Co Ltd Opioid Induced Constipation (OIC) Drugs Sales (K Pcs) and Growth Rate (2012-2017)
Figure Daiichi Sankyo Co Ltd Opioid Induced Constipation (OIC) Drugs Sales Market Share in EMEA (2012-2017)
Figure Daiichi Sankyo Co Ltd Opioid Induced Constipation (OIC) Drugs Revenue Market Share in EMEA (2012-2017)
Table Pfizer Opioid Induced Constipation (OIC) Drugs Basic Information List
Table Pfizer Opioid Induced Constipation (OIC) Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Pfizer Opioid Induced Constipation (OIC) Drugs Sales (K Pcs) and Growth Rate (2012-2017)
Figure Pfizer Opioid Induced Constipation (OIC) Drugs Sales Market Share in EMEA (2012-2017)
Figure Pfizer Opioid Induced Constipation (OIC) Drugs Revenue Market Share in EMEA (2012-2017)
Table Progenics Pharmaceuticals Inc Opioid Induced Constipation (OIC) Drugs Basic Information List
Table Progenics Pharmaceuticals Inc Opioid Induced Constipation (OIC) Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Progenics Pharmaceuticals Inc Opioid Induced Constipation (OIC) Drugs Sales (K Pcs) and Growth Rate (2012-2017)
Figure Progenics Pharmaceuticals Inc Opioid Induced Constipation (OIC) Drugs Sales Market Share in EMEA (2012-2017)
Figure Progenics Pharmaceuticals Inc Opioid Induced Constipation (OIC) Drugs Revenue Market Share in EMEA (2012-2017)
Table Shionogi & Co., Ltd Opioid Induced Constipation (OIC) Drugs Basic Information List
Table Shionogi & Co., Ltd Opioid Induced Constipation (OIC) Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Shionogi & Co., Ltd Opioid Induced Constipation (OIC) Drugs Sales (K Pcs) and Growth Rate (2012-2017)
Figure Shionogi & Co., Ltd Opioid Induced Constipation (OIC) Drugs Sales Market Share in EMEA (2012-2017)
Figure Shionogi & Co., Ltd Opioid Induced Constipation (OIC) Drugs Revenue Market Share in EMEA (2012-2017)
Table Allergan Plc Opioid Induced Constipation (OIC) Drugs Basic Information List
Table Allergan Plc Opioid Induced Constipation (OIC) Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Allergan Plc Opioid Induced Constipation (OIC) Drugs Sales (K Pcs) and Growth Rate (2012-2017)
Figure Allergan Plc Opioid Induced Constipation (OIC) Drugs Sales Market Share in EMEA (2012-2017)
Figure Allergan Plc Opioid Induced Constipation (OIC) Drugs Revenue Market Share in EMEA (2012-2017)
Table Nektar Therapeutics Opioid Induced Constipation (OIC) Drugs Basic Information List
Table Nektar Therapeutics Opioid Induced Constipation (OIC) Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Nektar Therapeutics Opioid Induced Constipation (OIC) Drugs Sales (K Pcs) and Growth Rate (2012-2017)
Figure Nektar Therapeutics Opioid Induced Constipation (OIC) Drugs Sales Market Share in EMEA (2012-2017)
Figure Nektar Therapeutics Opioid Induced Constipation (OIC) Drugs Revenue Market Share in EMEA (2012-2017)
Table Purdue Pharma Opioid Induced Constipation (OIC) Drugs Basic Information List
Table Purdue Pharma Opioid Induced Constipation (OIC) Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Purdue Pharma Opioid Induced Constipation (OIC) Drugs Sales (K Pcs) and Growth Rate (2012-2017)
Figure Purdue Pharma Opioid Induced Constipation (OIC) Drugs Sales Market Share in EMEA (2012-2017)
Figure Purdue Pharma Opioid Induced Constipation (OIC) Drugs Revenue Market Share in EMEA (2012-2017)
Table S.L.A. Pharma AG Opioid Induced Constipation (OIC) Drugs Basic Information List
Table S.L.A. Pharma AG Opioid Induced Constipation (OIC) Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure S.L.A. Pharma AG Opioid Induced Constipation (OIC) Drugs Sales (K Pcs) and Growth Rate (2012-2017)
Figure S.L.A. Pharma AG Opioid Induced Constipation (OIC) Drugs Sales Market Share in EMEA (2012-2017)
Figure S.L.A. Pharma AG Opioid Induced Constipation (OIC) Drugs Revenue Market Share in EMEA (2012-2017)
Table Mundipharma International Limited Opioid Induced Constipation (OIC) Drugs Basic Information List
Table Mundipharma International Limited Opioid Induced Constipation (OIC) Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Mundipharma International Limited Opioid Induced Constipation (OIC) Drugs Sales (K Pcs) and Growth Rate (2012-2017)
Figure Mundipharma International Limited Opioid Induced Constipation (OIC) Drugs Sales Market Share in EMEA (2012-2017)
Figure Mundipharma International Limited Opioid Induced Constipation (OIC) Drugs Revenue Market Share in EMEA (2012-2017)
Table Ono Pharmaceutical Co., Ltd Opioid Induced Constipation (OIC) Drugs Basic Information List
Table Takeda Pharmaceutical Company Limited Opioid Induced Constipation (OIC) Drugs Basic Information List
Table Theravance Biopharma Inc Opioid Induced Constipation (OIC) Drugs Basic Information List
Table Valeant Pharmaceuticals International Opioid Induced Constipation (OIC) Drugs Basic Information List
Table Cosmo Pharmaceuticals SA Opioid Induced Constipation (OIC) Drugs Basic Information List
Table Daewoong Pharmaceutical Opioid Induced Constipation (OIC) Drugs Basic Information List
Table C.B. Fleet Company Opioid Induced Constipation (OIC) Drugs Basic Information List
Table Sucampo Pharmaceuticals Opioid Induced Constipation (OIC) Drugs Basic Information List
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Opioid Induced Constipation (OIC) Drugs
Figure Manufacturing Process Analysis of Opioid Induced Constipation (OIC) Drugs
Figure Opioid Induced Constipation (OIC) Drugs Industrial Chain Analysis
Table Raw Materials Sources of Opioid Induced Constipation (OIC) Drugs Major Manufacturers in 2016
Table Major Buyers of Opioid Induced Constipation (OIC) Drugs
Table Distributors/Traders List
Figure EMEA Opioid Induced Constipation (OIC) Drugs Sales (K Pcs) and Growth Rate Forecast (2017-2022)
Figure EMEA Opioid Induced Constipation (OIC) Drugs Revenue and Growth Rate Forecast (2017-2022)
Figure EMEA Opioid Induced Constipation (OIC) Drugs Price (USD/Pcs) and Trend Forecast (2017-2022)
Table EMEA Opioid Induced Constipation (OIC) Drugs Sales (K Pcs) Forecast by Region (2017-2022)
Figure EMEA Opioid Induced Constipation (OIC) Drugs Sales Market Share Forecast by Region (2017-2022)
Table EMEA Opioid Induced Constipation (OIC) Drugs Revenue (Million USD) Forecast by Region (2017-2022)
Figure EMEA Opioid Induced Constipation (OIC) Drugs Revenue Market Share Forecast by Region (2017-2022)
Table Europe Opioid Induced Constipation (OIC) Drugs Sales (K Pcs) Forecast by Countries (2017-2022)
Figure Europe Opioid Induced Constipation (OIC) Drugs Sales Market Share Forecast by Countries (2017-2022)
Table Europe Opioid Induced Constipation (OIC) Drugs Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Europe Opioid Induced Constipation (OIC) Drugs Revenue Market Share Forecast by Countries (2017-2022)
Table Middle East Opioid Induced Constipation (OIC) Drugs Sales (K Pcs) Forecast by Countries (2017-2022)
Figure Middle East Opioid Induced Constipation (OIC) Drugs Sales Market Share Forecast by Countries (2017-2022)
Table Middle East Opioid Induced Constipation (OIC) Drugs Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Middle East Opioid Induced Constipation (OIC) Drugs Revenue Market Share Forecast by Countries (2017-2022)
Table Africa Opioid Induced Constipation (OIC) Drugs Sales (K Pcs) Forecast by Countries (2017-2022)
Figure Africa Opioid Induced Constipation (OIC) Drugs Sales Market Share Forecast by Countries (2017-2022)
Table Africa Opioid Induced Constipation (OIC) Drugs Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Africa Opioid Induced Constipation (OIC) Drugs Revenue Market Share Forecast by Countries (2017-2022)
Table EMEA Opioid Induced Constipation (OIC) Drugs Sales (K Pcs) Forecast by Type (2017-2022)
Figure EMEA Opioid Induced Constipation (OIC) Drugs Sales Market Share Forecast by Type (2017-2022)
Table EMEA Opioid Induced Constipation (OIC) Drugs Sales (K Pcs) Forecast by Application (2017-2022)
Figure EMEA Opioid Induced Constipation (OIC) Drugs Sales Market Share Forecast by Application (2017-2022)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources